The potential of hyperbaric oxygen as a therapy for neurodegenerative diseases

Kovacs GG. Molecular pathology of neurodegenerative diseases: principles and practice. J Clin Pathol. 2019;72(11):725–35.

Article  CAS  Google Scholar 

Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9(7):a028035.

Article  Google Scholar 

Gammon K. Neurodegenerative disease: brain windfall. Nature. 2014;515(7526):299–300.

Article  Google Scholar 

Miller E, et al. Potential of redox therapies in neurodegenerative disorders. Frontiers in Bioscience-Elite. 2017;9(2):214–34.

Article  Google Scholar 

Shah J. Hyperbaric oxygen therapy. J Am Col Certif Wound Spec. 2010;2(1):9–13.

Google Scholar 

Kudchodkar B, et al. Hyperbaric oxygen treatment attenuates the pro-inflammatory and immune responses in apolipoprotein E knockout mice. Clin Immunol. 2008;128(3):435–41.

Article  CAS  Google Scholar 

Huang L, Obenaus A. Hyperbaric oxygen therapy for traumatic brain injury. Med Gas Res. 2011;1(1):21.

Article  Google Scholar 

Huang L, et al. Neuroprotective effect of hyperbaric oxygen therapy in a juvenile rat model of repetitive mild traumatic brain injury. Med Gas Res. 2016;6(4):187–93.

Article  CAS  Google Scholar 

Shapira R, et al. Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation. Neurobiol Aging. 2018;62:105–19.

Article  CAS  Google Scholar 

Hadanny A, Efrati S. The hyperoxic-hypoxic paradox. Biomolecules. 2020;10(6):958.

Article  CAS  Google Scholar 

Waypa GB, Smith KA, Schumacker PT. O2 sensing, mitochondria and ROS signaling: the fog is lifting. Mol Aspects Med. 2016;47:76–89.

Article  Google Scholar 

Simsek K, et al. Evaluation of the oxidative effect of long-term repetitive hyperbaric oxygen exposures on different brain regions of rats. Sci World J. 2012;2012:849183.

Article  Google Scholar 

Hajhosseini B, et al. Hyperbaric oxygen therapy: descriptive review of the technology and current application in chronic wounds. Plast Reconstr Surg Glob Open. 2020;8(9):e3136.

Article  Google Scholar 

Thom SR. Oxidative stress is fundamental to hyperbaric oxygen therapy. J Appl Physiol. 2009;106(3):988–95.

Article  CAS  Google Scholar 

Jain, K.K., The history of hyperbaric medicine. Textbook of hyperbaric medicine, 2017: 3–9

Edwards ML. Hyperbaric oxygen therapy. Part 1: history and principles. J Vet Emerg Crit Care (San Antonio). 2010;20(3):284–8.

Article  Google Scholar 

Simsek K, Sadir S, Oter S. The relation of hyperbaric oxygen with oxidative stress-reactive molecules in action. Oxid Antioxid Med Sci. 2015;4(1):17–22.

Article  Google Scholar 

Cannellotto M, et al. Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomised controlled trial. Emerg Med J. 2022;39(2):88–93.

Article  Google Scholar 

Levina O, et al. The safety of hyperbaric oxygen therapy in the treatment of COVID-19. Russ Sklifosovsky “J Emerg Med Care.” 2020;9(3):314–20.

Article  Google Scholar 

Leach RM, Rees PJ, Wilmshurst P. Hyperbaric oxygen therapy. BMJ. 1998;317(7166):1140–3.

Article  CAS  Google Scholar 

Somaa F. A review of the application of hyperbaric oxygen therapy in Alzheimer’s Disease. J Alzheimers Dis. 2021;81(4):1361–7.

Article  CAS  Google Scholar 

Bhatia D, et al. Hypoxia and its emerging therapeutics in neurodegenerative, inflammatory and renal diseases. Hypoxia Hum Dis. 2017;21:404–43.

Google Scholar 

Zhang Z, et al. Hypoxia inducible factor-1 as a target for neurodegenerative diseases. Curr Med Chem. 2011;18(28):4335–43.

Article  CAS  Google Scholar 

Altieri M, et al. Delayed poststroke dementia: a 4-year follow-up study. Neurol. 2004;62(12):2193–7.

Article  CAS  Google Scholar 

Honig LS, Kukull W, Mayeux R. Atherosclerosis and AD: analysis of data from the US National Alzheimer’s Coordinating Center. Neurol. 2005;64(3):494–500.

Article  Google Scholar 

Chao LL, et al. ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord. 2010;24(1):19–27.

Article  Google Scholar 

Chen JJ, Rosas HD, Salat DH. Age-associated reductions in cerebral blood flow are independent from regional atrophy. Neuroimage. 2011;55(2):468–78.

Article  Google Scholar 

Roher AE, et al. Cerebral blood flow in Alzheimer’s disease. Vasc Health Risk Manag. 2012;8:599–611.

Article  Google Scholar 

Zhang X, Le W. Pathological role of hypoxia in Alzheimer’s disease. Exp Neurol. 2010;223(2):299–303.

Article  CAS  Google Scholar 

Balasubramanian P, et al. Integrative role of hyperbaric oxygen therapy on healthspan, age-related vascular cognitive impairment, and dementia. Front Aging. 2021;2:678543.

Article  Google Scholar 

Gottfried I, Schottlender N, Ashery U. Hyperbaric oxygen treatment-from mechanisms to cognitive improvement. Biomolecules. 2021;11(10):1520.

Article  CAS  Google Scholar 

Hou Y, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565–81.

Article  Google Scholar 

Jacobs EA, et al. Hyperoxygenation effect on cognitive functioning in the aged. N Engl J Med. 1969;281(14):753–7.

Article  CAS  Google Scholar 

Hadanny A, et al. Cognitive enhancement of healthy older adults using hyperbaric oxygen: a randomized controlled trial. Aging (Albany NY). 2020;12(13):13740–61.

Google Scholar 

Shapira R, et al. Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer’s disease mouse model and in elderly patients. Aging (Albany NY). 2021;13(17):20935–61.

Article  CAS  Google Scholar 

Shwe T, et al. Hyperbaric oxygen therapy restores cognitive function and hippocampal pathologies in both aging and aging-obese rats. Mech Ageing Dev. 2021;195:111465.

Article  CAS  Google Scholar 

Chen C, et al. Hyperbaric oxygen prevents cognitive impairments in mice induced by D-galactose by improving cholinergic and anti-apoptotic functions. Neurochem Res. 2017;42(4):1240–53.

Article  CAS  Google Scholar 

Chen X, et al. Protective effect of hyperbaric oxygen on cognitive impairment induced by D-galactose in mice. Neurochem Res. 2016;41(11):3032–41.

Article  CAS  Google Scholar 

Boussi-Gross R, et al. Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury-randomized prospective trial. PLoS ONE. 2013;8(11):e79995.

Article  Google Scholar 

Boussi-Gross R, et al. Improvement of memory impairments in poststroke patients by hyperbaric oxygen therapy. Neuropsychol. 2015;29(4):610–21.

Article  Google Scholar 

Harch PG, Fogarty EF. Hyperbaric oxygen therapy for Alzheimer’s dementia with positron emission tomography imaging: a case report. Med Gas Res. 2018;8(4):181.

Article  CAS  Google Scholar 

Chen J, et al. Hyperbaric oxygen ameliorates cognitive impairment in patients with Alzheimer’s disease and amnestic mild cognitive impairment. Alzheimers Dement (N Y). 2020;6(1):e12030.

Google Scholar 

Xu JJ, et al. Hyperbaric oxygen treatment for Parkinson’s disease with severe depression and anxiety: a case report. Med (Baltimore). 2018;97(9):e0029.

Article  Google Scholar 

Steele J, et al. A Phase I safety study of hyperbaric oxygen therapy for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(4):250–4.

Article  CAS  Google Scholar 

Zhang LD, et al. Hyperbaric oxygen and ginkgo biloba extract ameliorate cognitive and memory impairment via nuclear factor kappa-B pathway in rat model of Alzheimer’s disease. Chin Med J (Engl). 2015;128(22):3088–93.

Article  CAS  Google Scholar 

Tian X, et al. The protective effect of hyperbaric oxygen and Ginkgo biloba extract on Aβ25–35-induced oxidative stress and neuronal apoptosis in rats. Behav Brain Res. 2013;242:1–8.

Article  CAS  Google Scholar 

Tian X, et al. Hyperbaric oxygen and Ginkgo Biloba extract inhibit Aβ25-35-induced toxicity and oxidative stress in vivo: a potential role in Alzheimer’s disease. Int J Neurosci. 2012;122(10):563–9.

Article  CAS  Google Scholar 

Zhao B, et al. Hyperbaric oxygen pretreatment improves cognition and reduces hippocampal damage via p38 mitogen-activated protein kinase in a rat model. Yonsei Med J. 2017;58(1):131–8.

Article  CAS  Google Scholar 

Pan X, et al. Neuroprotective effect of combined therapy with hyperbaric oxygen and madopar on 6-hydroxydopamine-induced Parkinson’s disease in rats. Neurosci Lett. 2015;600:220–5.

Article  CAS  Google Scholar 

Hsu HT, et al. Hyperbaric oxygen therapy improves Parkinson’s disease by promoting mitochondrial biogenesis via the SIRT-1/PGC-1α pathway. Biomolecules. 2022;12(5):661.

Article  CAS  Google Scholar 

Kusuda Y, et al. Mild hyperbaric oxygen inhibits the decrease of dopaminergic neurons in the substantia nigra of mice with MPTP-induced Parkinson’s disease. Neurosci Res. 2018;132:58–62.

Article  CAS 

留言 (0)

沒有登入
gif